OCS Lung: The TransMedics Organ Care System (OCS) Lung is an FDA approved portable extracorporeal lung perfusion and monitoring system.
The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
| Facility | City | Region | Status |
|---|---|---|---|
| St. Joseph's Hospital & Medical Center | Phoenix | Arizona | Recruiting |
| Stanford University School of Medicine | Stanford | California | Recruiting |
| University of Minnesota | Minneapolis | Minnesota | Recruiting |
| Duke University | Durham | North Carolina | Recruiting |
| Baylor Scott & White Research Institute | Dallas | Texas | Recruiting |
| Baylor College of Medicine | Houston | Texas | Recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06513091 on ClinicalTrials.gov ↗ ← All trials in the USA